G
Genmab A/S
Q3 2026 earnings expected
Quarter
Jul – Sep
Expected
November 5, 2026(ET)
Revenue
This quarter$1.2B
Analyst estimate$1.2B▲ +0.0%
Year ago (Sep '25)$1.0B▲ +18.2%
Revenue Growth Trajectory
+25%YoY
Last 6 quarters
Analyst consensus · $1.2B · 6 analysts
As of 9/1, 06:04 KST